David Elashoff

31.1k total citations · 2 hit papers
384 papers, 14.9k citations indexed

About

David Elashoff is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, David Elashoff has authored 384 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 78 papers in Molecular Biology and 62 papers in Surgery. Recurrent topics in David Elashoff's work include Prostate Cancer Treatment and Research (24 papers), Rheumatoid Arthritis Research and Therapies (22 papers) and Prostate Cancer Diagnosis and Treatment (19 papers). David Elashoff is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Rheumatoid Arthritis Research and Therapies (22 papers) and Prostate Cancer Diagnosis and Treatment (19 papers). David Elashoff collaborates with scholars based in United States, Germany and Japan. David Elashoff's co-authors include David T. Wong, Elliot Abemayor, Tristan Grogan, William J. Aronson, Maie A. St. John, Dave S.�B. Hoon, Bradley S. Henson, Noh Jin Park, Dragana Kastratović and Hui Zhou and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

David Elashoff

376 papers receiving 14.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection

2009 682 citations Noh Jin Park, Hui Zhou et al. Clinical Cancer Research profile →
Propionibacterium acnes Strain Populations in the Human Skin Microbiome Associated with Acne

2013 528 citations David Elashoff et al. profile →

Peers

Countries citing papers authored by David Elashoff

Since Specialization

Citations

This map shows the geographic impact of David Elashoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Elashoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Elashoff more than expected).

Fields of papers citing papers by David Elashoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Elashoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Elashoff. The network helps show where David Elashoff may publish in the future.

Co-authorship network of co-authors of David Elashoff

This figure shows the co-authorship network connecting the top 25 collaborators of David Elashoff. A scholar is included among the top collaborators of David Elashoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Elashoff. David Elashoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren’s syndrome and Sicca 2024 ·RMD Open ·(unknown), Tristan Grogan, (unknown), Wei Bin Fang, Nabihah Tayob, (unknown), Jin Kyun Park, David Akin, David Elashoff, Anne Marie Lynge Pedersen, Yeong Wook Song, David T. Wong, David Chia	2
2	Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis 2023 ·Rheumatology International ·Christina Charles‐Schoeman, Jennifer Wang, Ani Shahbazian, (unknown), Jenny Brook, Gurjit S. Kaeley, (unknown), Ami Ben‐Artzi, David Elashoff, Veena K. Ranganath	3
3	Twelve-Month Reach and Effectiveness of a University-Based Diabetes Prevention Initiative 2023 ·American Journal of Preventive Medicine ·Maryam Gholami, Nicholas Jackson, Tamra Burns Loeb, (unknown), (unknown), (unknown), (unknown), David Elashoff, Alison Brown, Carol M. Mangione, O. Kenrik Duru, Tannaz Moin	1
4	Nanoscale Extracellular Vesicles Carry the Mechanobiology Signatures of Breast Cancer Cells 2021 ·ACS Applied Nano Materials ·(unknown), James A. Wohlschlegel, Helena R. Chang, Madhuri Wadehra, (unknown), Jianyu Rao, David Elashoff, James K. Gimzewski, Shivani Sharma	12
5	Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer 2021 ·Cancers ·(unknown), (unknown), Linh M. Tran, Raymond J. Lim, Camelia Dumitras, Tristan Grogan, David Elashoff, Ramin Salehi‐Rad, Steven M. Dubinett, Bin Liu, Claudio Scafoglio	5
6	Significance of Coronary Artery Calcium Found on Non–Electrocardiogram-Gated Computed Tomography During Preoperative Evaluation for Liver Transplant 2019 ·The American Journal of Cardiology ·Brian West, (unknown), (unknown), Eric H. Yang, Gabriel Vorobiof, Ronald W. Busuttil, Matthew J. Budoff, David Elashoff, Jonathan M. Tobis, Henry M. Honda	17
7	Usefulness of Trends in Continuous Electrocardiographic Telemetry Monitoring to Predict In-Hospital Cardiac Arrest 2019 ·The American Journal of Cardiology ·Duc H., (unknown), Edward S. Lee, David Mortara, David Elashoff, Xiao Hu, Noel G. Boyle	13
8	Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases 2018 ·Clinical Breast Cancer ·William Hsu, Xinkai Zhou, (unknown), (unknown), Stephanie Lee‐Felker, (unknown), Neil S. Wenger, David Elashoff, Arash Naeim	10
9	Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience 2016 ·Journal of Clinical and Translational Hepatology ·Victoria Sheen, (unknown), Melissa Jimenez, Vatche G. Agopian, Sitaram Vangala, David Elashoff, Sammy Saab	3
10	Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use 2016 ·Journal of Clinical and Translational Hepatology ·Sammy Saab, (unknown), Melissa Jimenez, (unknown), Gina Choi, Francisco Durazo, (unknown), Steven Han, (unknown), (unknown), Jonathan Grotts, David Elashoff, Ronald W. Busuttil	15
11	PGE2-Driven Expression of c-Myc and OncomiR-17-92 Contributes to Apoptosis Resistance in NSCLC 2014 ·Molecular Cancer Research ·Kostyantyn Krysan, Rebecca Kusko, Tristan Grogan, (unknown), Karen L. Reckamp, Tonya C. Walser, Edward B. Garon, Marc E. Lenburg, Sherven Sharma, Avrum Spira, David Elashoff, Steven M. Dubinett	36
12	Molecular Profiling of Premalignant Lesions in Lung Squamous Cell Carcinomas Identifies Mechanisms Involved in Stepwise Carcinogenesis 2014 ·Cancer Prevention Research ·Aik T. Ooi, Adam C. Gower, Kelvin X. Zhang, Jessica Vick, Longsheng Hong, (unknown), William D. Wallace, David Elashoff, Tonya C. Walser, Steven M. Dubinett, Matteo Pellegrini, Marc E. Lenburg, Avrum Spira, Brigitte N. Gomperts	59
13	Discovery and Prevalidation of Salivary Extracellular microRNA Biomarkers Panel for the Noninvasive Detection of Benign and Malignant Parotid Gland Tumors 2013 ·Clinical Cancer Research ·(unknown), Janice Yoshizawa, Xiaoyan Wang, David Elashoff, Jan G.M. Bolscher, Enno C.I. Veerman, Elisabeth Bloemena, David T. Wong	51
14	Phase II Prospective Randomized Trial of a Low-Fat Diet with Fish Oil Supplementation in Men Undergoing Radical Prostatectomy 2011 ·Cancer Prevention Research ·William J. Aronson, Naoko Kobayashi, R. James Barnard, Susanne M. Henning, Min Huang, Patricia Jardack, Bing-Rong Liu, Ashley Gray, Junxiang Wan, Ramdev Konijeti, Stephen J. Freedland, Brandon Castor, David Heber, David Elashoff, Jonathan Said, Pinchas Cohen, Colette Galet	61
15	FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer 2010 ·Cancer Research ·Partha Ray, Jinhua Wang, Ying Qu, Myung‐Shin Sim, Jaime Shamonki, Sanjay P. Bagaria, Xing Ye, Bingya Liu, David Elashoff, Dave S.�B. Hoon, Michael A. Walter, John W.M. Martens, Andrea L. Richardson, Armando E. Giuliano, Xiaojiang Cui	199
16	Electrochemical Sensor for Multiplex Biomarkers Detection 2009 ·Clinical Cancer Research ·Wei Fang, Prabhudas S. Patel, Wei Liao, Kishore Chaudhry, Lei Zhang, Martha Arellano-Garcia, Shen Hu, David Elashoff, Hui Zhou, Shilin N. Shukla, Franky D. Shah, Chih‐Ming Ho, David T. Wong	213
17	Snail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung Carcinoma 2009 ·Clinical Cancer Research ·Jane Yanagawa, Tonya C. Walser, Li Zhu, Longsheng Hong, Michael C. Fishbein, Vei Mah, David Chia, Lee Goodglick, David Elashoff, Jie Luo, Clara E. Magyar, Mariam Dohadwala, Jay M. Lee, Maie A. St. John, Robert M. Strieter, Sherven Sharma, Steven M. Dubinett	99
18	Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection breakdown → 2009 ·Clinical Cancer Research ·Noh Jin Park, Hui Zhou, David Elashoff, Bradley S. Henson, Dragana Kastratović, Elliot Abemayor, David T. Wong	682
19	Effect of Low-Fat Diet on Development of Prostate Cancer and Akt Phosphorylation in the Hi-Myc Transgenic Mouse Model 2008 ·Cancer Research ·Naoko Kobayashi, R. James Barnard, Jonathan Said, (unknown), (unknown), (unknown), Ngan Doan, Dorina Gui, David Elashoff, Pinchas Cohen, William J. Aronson	64
20	Effect of Altering Dietary ω-6/ω-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2 2006 ·Clinical Cancer Research ·Naoko Kobayashi, R. James Barnard, Susanne M. Henning, David Elashoff, Srinivasa T. Reddy, Pinchas Cohen, Pak Shan Leung, (unknown), Stephen J. Freedland, Jonathan Said, Dorina Gui, Navindra P. Seeram, Laura M. Popoviciu, Dilprit Bagga, David Heber, John A. Glaspy, William J. Aronson	131

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact